🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Listen Here: podcasts.apple.com/us/podcast/inn… In this episode of the Becker's Healthcare Podcast, host Lukas Voss, MS explores cutting-edge advancements in gastric and esophageal cancer care with two leading experts from City of Hope. Surgical Oncologist Dr. Yanghee Woo and Medical

Focus on #ColorectalCancerAwarenessMonth and our #earlyonset #colorectalcancer patients. the-scientist.com/generation-x-a… Andreana N. Holowatyj 🇺🇦 #CancerResearch #cancer @VUMCHemOnc @VUMC_Cancer Vanderbilt University Medical Center

Just a few of the participants at the 15th Medical Oncology Advances Symposium! ⁦City of Hope Department of Medical Oncology⁩ strong! Over 100 registered! ⁦City of Hope⁩ ⁦City of Hope | Orange County⁩ Wonderful care of patients/family, great science/medicine!

It was wonderful to see our first-year resident presenting her work at MoASC. Thank you all for the tremendous support in clinical research and enthusiastic trainees.#MoASC

At the Cancer at Cedars-Sinai 6th Annual GI Symposium led by Jun Gong, Dr. Andrew Hendifar & Arsen Osipov, MD. Terrific meeting & wonderful talk by my City of Hope colleague & #gasticcancer expert Dani Castillo! If you’re not already, please give her a follow - definitely one to watch!!!

Sign up to lead one-on-one or group Career Conversations at #ASCO25! We invite you to share your professional expertise and guidance with other #ASCO25 attendees in these situational mentoring sessions ➡️brnw.ch/21wS9un

Amazing PanCAN walk this morning, our patients are so supported, dancing with City of Hope Cedars-Sinai RNs, families.

In the latest issue! Crop root bacterial and viral genomes reveal unexplored species and microbiome patterns dlvr.it/TKZ9p7

Polyps Removed, so Back Again in 3 years - Dr. Cathy Eng Vanderbilt University Medical Center oncodaily.com/blog/polyps-29… #Colonscopy #CRC #ColorectalCancer #GIOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Join me, Tian Zhang, MD, MHS & Dr. David McDermott for a PeerView x @KCCure symposium on personalized RCC care at #ASCO25, May 31 @ 7PM CDT! We’ll cover frontline IO combos, sequencing & AEs. Join us in Chicago or online - register here: shorturl.at/yk8Dg

🔥 Final analysis: CheckMate 577 Adjuvant nivolumab in resected stage II/III EC/GEJC post-CRT & surgery ✅ DFS benefit maintained 21.8 vs 10.8 mo HR 0.76 (95% CI 0.63–0.91) 🧠 DMFS improved 27.3 vs 14.6 mo HR 0.75 (95% CI 0.62–0.90) ⚠️ OS not statistically significant 51.7 vs

This is what excites me. #PrecisionOncology agnostic of tissue type. We enrolled patients with a variety of cancers to this 1st AGNOSTIC PARP⛔️trial. Long journey. Finally over the finishing line. 🧬BRCA, PALB2, RAD, BARD, & more. 🔗meetings.asco.org/abstracts-pres… #ASCO25 OncoAlert

Can't do this without Tian Zhang, MD, MHS . amazing mentoring at UTSW Simmons Cancer Center . Thank you Conquer Cancer, the ASCO Foundation . I look forward to doing something great for all patients!

Meeting GI onc mentors at ASCO @ascoGI Dr. Cathy Eng

We’re excited for another day at #ASCO25! From groundbreaking research to inspiring conversations, there’s so much to explore and learn. If you’re attending, come say hello! City of Hope is at Booth No. 36082 and we’d love to connect.

Proud of this terrific work from our VP, Sumanta K. Pal, MD, FASCO City of Hope!

1st Plenary #ASCO25: #ATOMIC Ph III, adj mFOLFOX + Atezolizumab vs. mFOLFOX in Stg III dMMR colon ca. - 3yr DFS 86.4% vs 76.6% (HR 0.50), benefit seen in all subgroups. DFS 100% in Niche2 - ⬆️ discontinuation w/ Atezo - OS not mature - ⬆️ Gr4 neutropenia - To Adj or to NeoAdj?

#ASCO25: Researchers debate how best to use checkpoint drugs in earlier cancers - endpts.com/asco25-researc…

#ASCO25: Promising news for patients with advanced #colorectalcancer. Pashtoon Kasi MD, MS, Medical Director of GI Medical Oncology at City of Hope | Orange County, recaps breakthrough findings presented by Dr. Marwan G. Fakih — highlighting new hope in the form of next-generation immunotherapies.

#ASCO25: City of Hope’s Sumanta K. Pal, MD, FASCO breaks down IMmotion010 — a phase 3 #clinicaltrial aiming to uncover the mechanisms behind therapy resistance in patients with localized #kidneycancer.